Stay up to date with news and events
2024: Year in Review
January 4, 2025
As we wave goodbye to 2024, the HDBuzz team reflects on a year marked by significant progress, challenges, and hope. From breakthroughs at the lab…
2024 HDBuzz Prize: A NEAT new dance partner for Huntingtin
December 25, 2024
Proteins are like molecular dancers, with the cell acting as their dance floor. Proteins pair up with various partners to perform elaborate dances. Depending on…
Beta-blockers associated with delayed onset and decreased progression of Huntington’s disease
December 17, 2024
Research led by Dr. Peg Nopoulos from the University of Iowa used the Enroll-HD database to answer a key question: “How does beta-blocker use influence…
Interim update from Vico Therapeutics on their CAG-targeting drug, VO659
December 10, 2024
Vico Therapeutics recently presented at several conferences to share an interim update on their Phase 1/2a clinical trial testing their drug called VO659, which targets…
Going boldly: First person treated in Phase 1 clinical trial by Alnylam Pharmaceuticals
December 8, 2024
On December 3, 2024 we received word that the very first person received a new drug, called ALN-HTT02, as part of a Phase 1 trial…